Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Scope Of Study
2.5. Crisis Scenario Analysis
2.6. Major Market Findings
2.6.1. Software And Services Sector Emerges As The Rapidly Expanding Product & Service Segment
2.6.2. Protein-Based Multiplex Assay Is The Highest Revenue-Generating Type
2.6.3. Research & Development Applications Dominate Market Share
2.6.4. Multiplex Pcr Technology Demonstrates Faster Growth
2.6.5. Pharmaceutical And Biotechnology Companies Are Major Users Of Multiplex Assays

3. Market Dynamics
3.1. Key Drivers
3.1.1. Escalating Incidence Of Chronic Diseases
3.1.2. Growing Preference For Multiplex Assays Over Conventional Approaches
3.1.3. Increasing Acceptance Of Personalized Medicine
3.2. Key Restraints
3.2.1. Overcoming The Difficulty Of Establishing Sufficient Assay Range
3.2.2. Challenges Associated With Cross-Reactivity And Assay Interference
3.2.3. Shortage Of Skilled Professionals

4. Key Analytics
4.1. Key Market Trends
4.1.1. Rising Drug Discovery Endeavors
4.1.2. Progress In Assay Platform Technology
4.1.3. Rapid Expansion Of Companion Diagnostics
4.2. Pestle Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Legal
4.2.6. Environmental
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Market Concentration Analysis
4.5. Key Buying Criteria
4.5.1. Coverage Of Analytes
4.5.2. Rapidity
4.5.3. Ability To Multiplex
4.5.4. User-Friendliness
4.5.5. Automation Potential
4.6. Value Chain Analysis
4.6.1. Research And Development (R&D)
4.6.2. Manufacturing And Production
4.6.3. Distribution And Supply Chain
4.6.4. Clinical Application And Data Analysis
4.6.5. Market Research And Commercialization

5. Market By Product And Service
5.1. Reagents And Consumables
5.1.1. Market Forecast Figure
5.1.2. Segment Analysis
5.2. Instruments And Accessories
5.2.1. Market Forecast Figure
5.2.2. Segment Analysis
5.3. Software And Services
5.3.1. Market Forecast Figure
5.3.2. Segment Analysis

6. Market By Type
6.1. Protein-Based Multiplex Assay
6.1.1. Market Forecast Figure
6.1.2. Segment Analysis
6.2. Nucleic Acid-Based Multiplex Assay
6.2.1. Market Forecast Figure
6.2.2. Segment Analysis
6.3. Other Types
6.3.1. Market Forecast Figure
6.3.2. Segment Analysis

7. Market By Application
7.1. Research And Development
7.1.1. Market Forecast Figure
7.1.2. Segment Analysis
7.2. Clinical Diagnostics
7.2.1. Market Forecast Figure
7.2.2. Segment Analysis
7.3. Companion Diagnostics
7.3.1. Market Forecast Figure
7.3.2. Segment Analysis

8. Market By Technology
8.1. Multiplex Protein Microarray
8.1.1. Market Forecast Figure
8.1.2. Segment Analysis
8.2. Multiplex Pcr
8.2.1. Market Forecast Figure
8.2.2. Segment Analysis
8.3. Other Technologies
8.3.1. Market Forecast Figure
8.3.2. Segment Analysis

9. Market By End-User
9.1. Pharmaceutical & Biotechnology Companies
9.1.1. Market Forecast Figure
9.1.2. Segment Analysis
9.2. Research Institutes
9.2.1. Market Forecast Figure
9.2.2. Segment Analysis
9.3. Clinical Laboratories
9.3.1. Market Forecast Figure
9.3.2. Segment Analysis
9.4. Hospitals
9.4.1. Market Forecast Figure
9.4.2. Segment Analysis

10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions & Divestitures
10.2. Company Profiles
10.2.1. Agilent Technologies Inc
10.2.1.1. Company Overview
10.2.1.2. Product Portfolio
10.2.1.3. Strengths & Challenges
10.2.2. Becton, Dickinson And Company (Bd)
10.2.2.1. Company Overview
10.2.2.2. Product Portfolio
10.2.2.3. Strengths & Challenges
10.2.3. Bio-Rad Laboratories Inc
10.2.3.1. Company Overview
10.2.3.2. Product Portfolio
10.2.3.3. Strengths & Challenges
10.2.4. F. Hoffmann-La Roche Ltd
10.2.4.1. Company Overview
10.2.4.2. Product Portfolio
10.2.4.3. Strengths & Challenges
10.2.5. Illumina Inc
10.2.5.1. Company Overview
10.2.5.2. Product Portfolio
10.2.5.3. Strengths & Challenges
10.2.6. Qiagen Nv
10.2.6.1. Company Overview
10.2.6.2. Product Portfolio
10.2.6.3. Strengths & Challenges
10.2.7. Siemens Healthineers Ag
10.2.7.1. Company Overview
10.2.7.2. Product Portfolio
10.2.7.3. Strengths & Challenges
10.2.8. Thermo Fisher Scientific Inc
10.2.8.1. Company Overview
10.2.8.2. Product Portfolio
10.2.8.3. Strengths & Challenges



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Market Concentration Analysis
Figure 4: Key Buying Criteria
Figure 5: Value Chain Analysis
Figure 6: India Multiplex Assay Market, Growth Potential, By Product And Service, In 2023
Figure 7: India Multiplex Assay Market, By Reagents And Consumables, 2024-2032 (In $ Million)
Figure 8: India Multiplex Assay Market, By Instruments And Accessories, 2024-2032 (In $ Million)
Figure 9: India Multiplex Assay Market, By Software And Services, 2024-2032 (In $ Million)
Figure 10: India Multiplex Assay Market, Growth Potential, By Type, In 2023
Figure 11: India Multiplex Assay Market, By Protein-Based Multiplex Assay, 2024-2032 (In $ Million)
Figure 12: India Multiplex Assay Market, By Nucleic Acid-Based Multiplex Assay, 2024-2032 (In $ Million)
Figure 13: India Multiplex Assay Market, By Other Types, 2024-2032 (In $ Million)
Figure 14: India Multiplex Assay Market, Growth Potential, By Application, In 2023
Figure 15: India Multiplex Assay Market, By Research And Development, 2024-2032 (In $ Million)
Figure 16: India Multiplex Assay Market, By Clinical Diagnostics, 2024-2032 (In $ Million)
Figure 17: India Multiplex Assay Market, By Companion Diagnostics, 2024-2032 (In $ Million)
Figure 18: India Multiplex Assay Market, Growth Potential, By Technology, In 2023
Figure 19: India Multiplex Assay Market, By Multiplex Protein Microarray, 2024-2032 (In $ Million)
Figure 20: India Multiplex Assay Market, By Multiplex Pcr, 2024-2032 (In $ Million)
Figure 21: India Multiplex Assay Market, By Other Technologies, 2024-2032 (In $ Million)
Figure 22: India Multiplex Assay Market, Growth Potential, By End-User, In 2023
Figure 23: India Multiplex Assay Market, By Pharmaceutical & Biotechnology Companies, 2024-2032 (In $ Million)
Figure 24: India Multiplex Assay Market, By Research Institutes, 2024-2032 (In $ Million)
Figure 25: India Multiplex Assay Market, By Clinical Laboratories, 2024-2032 (In $ Million)
Figure 26: India Multiplex Assay Market, By Hospitals, 2024-2032 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – WOOD BASED PANEL
TABLE 2: INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: INDIA MULTIPLEX ASSAY MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: INDIA MULTIPLEX ASSAY MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: INDIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: INDIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: INDIA MULTIPLEX ASSAY MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: INDIA MULTIPLEX ASSAY MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES